115 related articles for article (PubMed ID: 9952194)
1. Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention Study.
Mason JM; Freemantle N
JAMA; 1999 Feb; 281(5):415-6; author reply 417-9. PubMed ID: 9952194
[No Abstract] [Full Text] [Related]
2. Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention Study.
Siegel D; Swislocki AL
JAMA; 1999 Feb; 281(5):417-9. PubMed ID: 9952198
[No Abstract] [Full Text] [Related]
3. Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention Study.
McDiarmid TD; Hensel WA
JAMA; 1999 Feb; 281(5):416; author reply 417-9. PubMed ID: 9952195
[No Abstract] [Full Text] [Related]
4. Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention Study.
Haq IU; Wallis EJ; Yeo WW; Jackson PR; Ramsay LE
JAMA; 1999 Feb; 281(5):414; author reply 417-9. PubMed ID: 9952191
[No Abstract] [Full Text] [Related]
5. Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention Study.
Krut LH
JAMA; 1999 Feb; 281(5):414; author reply 417-9. PubMed ID: 9952192
[No Abstract] [Full Text] [Related]
6. Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention Study.
Walsh J
JAMA; 1999 Feb; 281(5):416-7; author reply 417-9. PubMed ID: 9952197
[No Abstract] [Full Text] [Related]
7. Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention Study.
Papadakis JA; Mikhailidis DP
JAMA; 1999 Feb; 281(5):416; author reply 417-9. PubMed ID: 9952196
[No Abstract] [Full Text] [Related]
8. Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention Study.
Kandzari DE; Goldschmidt-Clermont PJ
JAMA; 1999 Feb; 281(5):415; author reply 417-9. PubMed ID: 9952193
[No Abstract] [Full Text] [Related]
9. Effect of lovastatin on cardiovascular resource utilization and costs in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). AFCAPS/TexCAPS Research Group.
Gotto AM; Boccuzzi SJ; Cook JR; Alexander CM; Roehm JB; Meyer GS; Clearfield M; Weis S; Whitney E
Am J Cardiol; 2000 Dec; 86(11):1176-81. PubMed ID: 11090787
[TBL] [Abstract][Full Text] [Related]
10. [AFCAPS/TexCAPS [The Air Force/Texas Coronary Atherosclerosis Prevention Study]].
Goto Y
Nihon Rinsho; 2001 Mar; 59 Suppl 3():398-403. PubMed ID: 11347102
[No Abstract] [Full Text] [Related]
11. Primary prevention of coronary heart disease: implications of the Air Force/Texas coronary atherosclerosis prevention study (AFCAPS/TexCAPS).
Brown AS
Curr Cardiol Rep; 2000 Sep; 2(5):439-44. PubMed ID: 10980912
[TBL] [Abstract][Full Text] [Related]
12. Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS): efficacy and tolerability of long-term treatment with lovastatin in women.
Clearfield M; Downs JR; Weis S; Whitney EJ; Kruyer W; Shapiro DR; Stein EA; Langendorfer A; Beere PA; Gotto AM
J Womens Health Gend Based Med; 2001 Dec; 10(10):971-81. PubMed ID: 11788107
[TBL] [Abstract][Full Text] [Related]
13. Plasma homocysteine concentration, statin therapy, and the risk of first acute coronary events.
Ridker PM; Shih J; Cook TJ; Clearfield M; Downs JR; Pradhan AD; Weis SE; Gotto AM;
Circulation; 2002 Apr; 105(15):1776-9. PubMed ID: 11956118
[TBL] [Abstract][Full Text] [Related]
14. Lipid management in patients at moderate risk for coronary heart disease: insights from the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS).
Gotto AM
Am J Med; 1999 Aug; 107(2A):36S-39S. PubMed ID: 10484239
[TBL] [Abstract][Full Text] [Related]
15. The 4S study and its pharmacoeconomic implications.
Reckless JP
Pharmacoeconomics; 1996 Feb; 9(2):101-5. PubMed ID: 10172696
[No Abstract] [Full Text] [Related]
16. Application of the National Cholesterol Education Program and joint European treatment criteria and clinical benefit in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS).
Gotto AM; Whitney E; Stein EA; Shapiro DR; Clearfield M; Weis S; Jou JY; Langendörfer A; Beere PA; Watson DJ; Downs JR; de Cani JS
Eur Heart J; 2000 Oct; 21(19):1627-33. PubMed ID: 10988016
[TBL] [Abstract][Full Text] [Related]
17. Establishing the benefit of statins in low-to-moderate--risk primary prevention: the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS).
Gotto AM
Atheroscler Suppl; 2007 Aug; 8(2):3-8. PubMed ID: 17588826
[TBL] [Abstract][Full Text] [Related]
18. Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS).
Gotto AM; Whitney E; Stein EA; Shapiro DR; Clearfield M; Weis S; Jou JY; Langendörfer A; Beere PA; Watson DJ; Downs JR; de Cani JS
Circulation; 2000 Feb; 101(5):477-84. PubMed ID: 10662743
[TBL] [Abstract][Full Text] [Related]
19. Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS): baseline characteristics and comparison with USA population.
Clearfield M; Whitney EJ; Weis S; Downs JR; Shapiro DR; Stein EA; Watson DJ; Langendörfer A; Beere PA; Stamler J; Gotto AM
J Cardiovasc Risk; 2000 Apr; 7(2):125-33. PubMed ID: 10879416
[TBL] [Abstract][Full Text] [Related]
20. Insights on treating an over-the-counter-type subgroup: data from the Air Force/Texas Coronary Atherosclerosis Prevention Study Population.
Gotto AM
Am J Cardiol; 2000 Jun; 85(12A):8E-14E. PubMed ID: 10858488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
